ONYX PHARMACEUTICALS INC Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-06-07: Reporting owner SHEMA SUZANNE M; Form 4; Security Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-04-19: Reporting owner SCHAFER GREGORY W; Form 3; Security No securities held.; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-06-07 | SHEMA SUZANNE M Officer (EVP, GC and Corp. Secretary) | 4 | Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −802 17,646 owned after | $35.18 exercise price | 2013-06-11 | |
| 2006-04-19 holding as of filing | SCHAFER GREGORY W Officer (Acting CFO) | 3 | No securities held. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2006-04-19 |